By Benjamin Horney ( August 10, 2015, 12:14 PM EDT) -- Irish drugmaker Mallinckrodt PLC has agreed to acquire Therakos Inc. from buyout firm The Gores Group for $1.33 billion, the companies said Monday, adding to Mallinckrodt's portfolio an immunotherapy company that has had success treating the likes of T-cell lymphoma and Crohn's disease, among others....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.